Ovarian cancer is among the most aggressive cancers, often progressing from stage one to stage four within a year. Early detection is critical, yet most cases are diagnosed too late, when survival rates plunge. A simple test that catches ovarian cancer early could save millions.
Denver7 News recently featured our portfolio company AOA Dx for its breakthrough AI-powered blood test, which achieved over 90% accuracy in detecting early-stage ovarian cancer in clinical trials. For reference, standard tests have less than 50% accuracy.
Video and full article here.
Denver7 News recently featured our portfolio company AOA Dx for its breakthrough AI-powered blood test, which achieved over 90% accuracy in detecting early-stage ovarian cancer in clinical trials. For reference, standard tests have less than 50% accuracy.
Video and full article here.